Form 8-K - Current report:
SEC Accession No. 0001193125-25-115554
Filing Date
2025-05-08
Accepted
2025-05-08 08:35:56
Documents
15
Period of Report
2025-05-05
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d924194d8k.htm   iXBRL 8-K 31427
2 EX-99.1 d924194dex991.htm EX-99.1 7437
6 GRAPHIC g924194g0508025241487.jpg GRAPHIC 2537
  Complete submission text file 0001193125-25-115554.txt   173749

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vor-20250505.xsd EX-101.SCH 2834
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20250505_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20250505_pre.xml EX-101.PRE 11697
17 EXTRACTED XBRL INSTANCE DOCUMENT d924194d8k_htm.xml XML 3767
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 25924084
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)